Back to Search
Start Over
P120 Cardiac safety of pertuzumab, trastuzumab and standard chemotherapy as neoadjuvant treatment for HER2 positive breast cancer: real world data from NeoPowER trial.
- Source :
- Breast; 2023 Supplement, Vol. 68, pS60-S60, 1p
- Publication Year :
- 2023
- Subjects :
- HER2 positive breast cancer
NEOADJUVANT chemotherapy
TRASTUZUMAB
Subjects
Details
- Language :
- English
- ISSN :
- 09609776
- Volume :
- 68
- Database :
- Supplemental Index
- Journal :
- Breast
- Publication Type :
- Academic Journal
- Accession number :
- 162439801
- Full Text :
- https://doi.org/10.1016/S0960-9776(23)00237-0